This topic contains a solution. Click here to go to the answer

Author Question: The second step in the program evaluation model in chapter 12, which asks What program activities ... (Read 273 times)

Tazate

  • Hero Member
  • *****
  • Posts: 532
The second step in the program evaluation model in chapter 12, which asks What program activities were implemented? and What was learned from these experiences?
 
  a. process evaluation
  b. progress evaluation
  c. outcome evaluation
  d. impacts evaluation

Question 2

Determining target groups and desired outcomes are elements of the ____ step of the four-step program evaluation model in chapter 13?
 
  a. first
  b. second
  c. needs assessment
  d. impacts



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

hramirez205

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

a

Answer to Question 2

a




Tazate

  • Member
  • Posts: 532
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


bitingbit

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library